aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
NeoGenomics Laboratories, based in Fort Myers, Florida, specializes in advanced cancer genetics diagnostic testing. The company offers a range of high-complexity CLIA-certified services, including cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. NeoGenomics serves both clinical and pharmaceutical markets, aiming to provide precise and comprehensive diagnostic information.
NeoGenomics has made significant strides in the field of cancer diagnostics, contributing to improved patient outcomes through innovative testing solutions. The company collaborates with leading healthcare providers and pharmaceutical firms to enhance cancer treatment and research. Its impact is evident in the widespread adoption of its diagnostic services, which support personalized medicine and targeted therapies.
Operating Status
Acquired
Ownership Type(s)
Public
Main Product(s)
Cancer Diagnostics
Technology
Analytics
Tags
Biotech, Healthtech
Model Types
Software, Data
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Government
Geographic Exposure
United States
When was NeoGenomics Laboratories founded?
NeoGenomics Laboratories was founded in 2002.
Where is NeoGenomics Laboratories’s headquarters located?
NeoGenomics Laboratories’s headquarters is located in Fort Myers, FL, US.
When was NeoGenomics Laboratories’s last funding round?
NeoGenomics Laboratories’s most recent funding round was for $200M (USD) in May 2021.
How many employees does NeoGenomics Laboratories have?
NeoGenomics Laboratories has 2100 employees as of Feb 5, 2024.
How much has NeoGenomics Laboratories raised to-date?
As of July 05, 2023, NeoGenomics Laboratories has raised a total of $350.5M (USD) since May 5, 2021.
Add Comparison
Total Raised to Date
$350.5M
USD
Last Update May 5, 2021
Last Deal Details
$200M
USD
May 5, 2021
Post Ipo Equity
Total Employees Over Time
2100
As of Feb 2024
NeoGenomics Laboratories Address
Fort Myers,
Florida
33916
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts